Characterization of a DNA binding site that mediates the stimulatory effect of cyclosporin-A on type III collagen expression in renal cells

Nephrology Dialysis Transplantation

Volumn 15, Issue 6, 2000, Pages 778-785

  Oleggini, Roberta ^a   Musante, Luca ^a   Menoni, Stefania ^a   Botti, Gerardo ^a   Di Duca, Marco ^a   Prudenziati, Michela ^b   Carrea, Alba ^a   Ravazzolo, Roberto ^b   Ghiggeri, Gian Marco ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

COL3A1; Cyclosporin; Renal fibrosis; Type III collagen

Indexed keywords

COLLAGEN TYPE 3; CYCLOSPORIN A; MESSENGER RNA; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG DNA BINDING; GENETIC TRANSFECTION; IMMUNOBLOTTING; KIDNEY CELL; KIDNEY FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CERCOPITHECUS AETHIOPS; COLLAGEN; CYCLOSPORINE; DNA; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 0034023731     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.6.778     Document Type: Article

References (30)

1. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine associated chronic ncphropathy. N Engl J Med 1984; 311: 699-705
2. Greenberg A, Thompson ME, Griffith BJ et al. Cyclosporine nephrotoxicity in cardiac allograft patients. A seven year follow-up. Transplantation 1990; 50: 589-593
3. Feutren G, Mihatsh MJ. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992; 326: 1654-1660
4. Bertani T, Ferrazzi P, Schieppati A et al. Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 1991; 40: 243-250
5. Mihatsch MJ., Ryffel B, Gudat F. The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int 1995; 48: 963-968
6. Jones CL, Buch S, Post M, Culloch MC, Liu E, Eddy AA. Pathogenesis of interstitial fibrosis in chronic purine aminonucleotide nephrosis. Kidney Int 1991; 40: 1020-1034
7. Siegl H, Ryffel B, Petrie R et al. Cyclosporine, the renin angiotensin aldosterone system and renal adverse rejections. Transplant Proc 1983; 15: 2719-2725
8. Tufro-McReddie A, Gomez RA, Norling LL, Omar AA, Moore LC, Kaskel FJ. Effect of cyclosporine on the expression of renin and angiotensin type 1 receptor genes in the rat kidney. Kidney Int 1993; 43: 615-622
9. Burdmann EA, Andoh TF, Nast CC et al. Prevention of experimental cyclosporine-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 1995; 269: F49-F499
10. 1 and its receptor by cyclosporine in human lymphocytes. Transplantation 1995; 60: 718-723
11. Shehata M, Cope GH, Johnson TS, Raftery AT, El Nahas AM. Cyclosporine enhances the expression of TGFβ in the juxtaglomerular cells in the rat. Kidney Int 1994; 46: 726-732
12. Shihab FS, Tanner AM, Shao Y, Weffer MI. Expression of TGFβ1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int 1996; 50: 1904-1913
13. Shehala M, El Nahas AM, Barkworth E, Cope GH, Raftery AT. Increased platelet-derived growth factor in the kidneys of cyclosporine-treated rats. Kidney Int 1994; 46: 726-732
14. Border WA, Noble NA. TGFβ in kidney fibrosis: A target for gene therapy. Kidney Int 1997; 71: 1388-1396
15. Pinzani M, Miloni S, Herbst H et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol 1996; 148: 785-800
16. Ghiggeri GM, Altieri P, Oleggini R et al. Cyclosporine enhances the synthesis of selected extracellular matrix proteins by renal cells in culture. Transplantation 1994; 57: 1382-1388
17. Nast CC, Adler SG, Artishevsky A, Kresse CK, Ahmed K, Anderson PS. Cyclosporine induces elevated protocollagen 1 (1) mRNA levels in the rat cortex. Kidney Int 1991; 39: 631-640
18. Benson-Chada V, Su MW, Weil D, Chu ML, Ramirez F. Cloning and analysis of the 5í portion of the human type-III protocollagen gene (COL3A1). Gene 1989; 78: 255-265
19. Higuchi M, Krummel B, Saiki RK A. general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res 1988; 16: 7351-7367
20. Chen C, Okayama H. High efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745-2752
21. Xu GG, Rothenberg PL. Insulin receptor signaling in the beta-cell influences insulin gene expression and insulin content: evidence for autocrine beta-cell regulation. Diabetes 1998; 47: 1243-1252
22. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475-1489
23. Beisiengel U. Protein blotting. Electrophoresis 1986; 7: 1-18
24. Barresi R, Sirito M, Karsenty G, Ravazzolo R. A negative cis-acting G-fer element participates in the regulation of expression of the human H-ferritin-encoding gene (FERN). Gene 1994; 140: 195-201
25. Bertelli R, Valenti F, Oleggini R et al. Cell specific regulation of α1 (III) and α2(V) collagen by TGFβ in animal tubulointerstitial cell models. Nephrol Dial Transplant 1998; 13: 573-579
26. English J, Evan A, Houghton DC, Bennett WM. Cyclosporine induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation 1987; 44: 135-141
27. Perico N, Ruggenenti P, Gaspari F et al. Daily renal hypoper-fusion induced by cyclosporine in patients with renal transplantation. Transplantation 1992; 54: 56-60
28. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcincurin is a common target of cyclophilin cyclosporine A and FKBP-FK 506 complex. Cell 1991; 66: 807-815
29. Schreibner SL., Crabtree GR. The mechanism of action of cyclosporine A and FK 506. Immunol Today 1992; 13: 136-142
30. Muraoka K, Fujimoto K, Sun X et al. Immunosuppressant FK506 induces interleukin-6 production through the activation of transcriptional factor nuclear factor (NK)-KB. J Clin Invest 1996; 97: 2433-2439